It has also been suggested that NF-κB is overactive in the cortex in people with schizophrenia and drives neuroinflammation due to decreased expression of the NF-κB inhibitor, human immunodeficiency virus type 1 enhancer binding protein 2 (HIVEP2) [62]. Here, NFKB1 is linked to schizophrenia.